As a newly formed joint venture located in China,
Medicilon/MPI Preclinical Research Shanghai provides a portfolio of
preclinical discovery and development services to pharmaceutical and
biotechnology companies. The
new company has brought the best of its parent companies, Shanghai
Medicilon and MPI Research, to assure top quality, on-time GLP and
non-GLP studies. With its global team of talented scientific
professionals, the latest technology, and a problem-solving culture,
Medicilon/MPI Preclinical Research Shanghai welcomes your toughest
preclinical research challenges.
| |
|
Medicilon/MPI Preclinical Research Shanghai News
|
|
|
|
|
|
|
